MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Impact of Genetically Defined Ancestry on Progression of Idiopathic Parkinson’s Disease.

    J. Frost, S. Gray-Rodriguez, L. Wu, M. Lawton, Y. Ben-Shlomo, M. Hu, D. Grosset, R. Real, H. Morris (London, United Kingdom)

    Objective: To assess the impact of genetically defined ancestry on progression of idiopathic Parkinson's Disease and evaluate the contribution of known genetic variation on any…
  • 2025 International Congress

    Effects of transmembrane protein 106B genetic variations on disease progression in Parkinson’s disease

    Y. Fan, W. Zhao, X. Liang, Y. Sun, J. Wang (Shanghai, China)

    Objective: This study aimed to explore whether the variants of Transmembrane protein 106B (TMEM106B) influence clinical phenotypes’ trajectory in Parkinson’s disease (PD). Background: TMEM106B variations are…
  • 2025 International Congress

    Subthalamic versus Pallidal Temporal Interference Stimulation in Parkinson’s Disease: A Pilot Study

    J. Li, A. Li, C. Zhang (Shanghai, China)

    Objective: To investigate whether transcranial temporal interference stimulation (tTIS) targeting different deep brain regions produces symptom-specific improvements consistent with established deep brain stimulation (DBS) outcomes…
  • 2025 International Congress

    Unraveling Parkinson’s Disease Heterogeneity: Variability in Dopaminergic Medication Response Over Five Years – A Cluster Analysis of PPMI Data

    N. Rajabli, M. Vakhshoori, A. Espay, J. Jones, A. Baghaei, K. Dashtipour (Loma Linda, USA)

    Objective: We sought to examine which demographic, genetic, and clinical characteristics inParkinson’s disease (PD) are associated with differences in levodopa equivalent daily dose(LEDD) at five…
  • 2025 International Congress

    Developing Competency-Based Training Modules for Health Professionals in Parkinson’s Disease Management: A Review of Current Practices and Future Needs

    M. Alfeky, M. Alomari, N. Bekhit, F. Sakr, A. Hafez, O. Awadalla, M. M. Elsayed (Giza, Egypt)

    Objective: To review existing competency-based training programs for health professionals in Parkinson’s disease (PD) management and identify future educational needs to enhance patient care. Background:…
  • 2025 International Congress

    Effect of Virtual Rehabilitation Therapy on Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis

    F. Luna-Rangel, B. Gonzalez-Bedolla, C. Armengol-Garcia, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: To assess the efficacy of virtual rehabilitation therapy compared to conventional physical therapy in patients with Parkinson’s disease. Background: Rehabilitation is essential in managing…
  • 2025 International Congress

    Association Between Trait Impulsivity and Freezing of Gait in People with Parkinson’s Disease

    H. Cavalcanti, D. Dos Santos, G. Valença, E. Pinto, J. Oliveira-Filho, L. de Almeida (Cachoeira, Brazil)

    Objective: To analyze the association between motor, attentional and non-planning impulsivity and freezing of gait in people with PD Background: Freezing of gait is a…
  • 2025 International Congress

    Quality of Life of Parkinson’s Disease Patients in the Thai Population: A Cross-Sectional Analysis

    C. Ounmuang, S. Rujirussawarawong, N. Limotai, S. Aungsumart, C. Kasemsuk (Bangkok, Thailand)

    Objective: Primary: To assess QoL in PD patients at the Neurological Institute of Thailand (NIT).Secondary: To identify clinical factors associated with QoL. Background: Parkinson’s disease…
  • 2025 International Congress

    Negative Correlation between Apathy and Executive Functioning in Patients with Idiopathic Parkinson’s Disease without Dementia.

    P. Andrea Gutiérrez-Lenis, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospinta-Otalvaro, A. Lucumi-Moreno, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, A. Maria Valencia-Orjuela (Cali, Colombia)

    Objective: To establish the impact of apathy on executive functioning in patients with IPDWD. Background: Executive Functioning is one of the domains of neurocognitive functioning…
  • 2025 International Congress

    Modeling Inflammation in GBA-Associated Parkinson’s Disease: Insights into Disease Mechanisms

    V. Lentini, G. Uras, S. Lucas, D. Moreno-Martinez, A. Manca, F. Fierli, S. Koletsi, A. Pantaleo, D. Hughes (Sassari, Italy)

    Objective: This investigation centers on the role of inflammation in GBA-associated Parkinson’s disease (PD), a neurodegenerative disorder characterized by the progressive degeneration of dopaminergic neurons,…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley